Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.050
0.00 (0.00%)
Sep 8, 2026, 4:00 PM EDT - Market closed

Apyx Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
128144599181440
Market Cap Growth
78.69%141.44%-34.47%12.12%-81.61%78.41%
Enterprise Value
140158708367410
Last Close Price
3.053.501.582.622.3412.82

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-267.00267.00267.00267.00267.00
PS Ratio
2.202.721.241.731.829.07
PB Ratio
12.059.684.153.372.148.15
P/TBV Ratio
12.059.884.193.402.158.20
PEG Ratio
-20.6320.6320.6320.6320.63

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2.412.991.471.591.518.45

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
3.572.652.701.430.020.01
Net Debt / Equity Ratio
1.080.510.49-0.19-0.25-0.57
Net Debt / EBITDA Ratio
-4.36-1.31-0.380.270.422.26
Net Debt / FCF Ratio
-1.09-0.83-0.370.890.442.74
Asset Turnover
0.980.800.670.800.740.68
Inventory Turnover
2.252.452.141.711.662.76
Quick Ratio
4.414.164.414.542.413.95
Current Ratio
5.685.005.265.523.634.60
Return on Equity (ROE)
-90.69%-76.15%-114.21%-58.26%-50.71%-25.79%
Return on Assets (ROA)
-3.71%-6.12%-16.35%-19.04%-24.18%-12.64%
Return on Capital Employed (ROCE)
-6.80%-11.70%-34.80%-30.00%-58.40%-26.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-6.72%-7.81%-39.45%-20.62%-28.64%-3.45%
FCF Yield
-8.60%-6.35%-31.56%-6.37%-26.30%-2.54%
Buyback Yield / Dilution
-10.48%-15.62%-2.66%-0.31%-0.54%-0.35%
SEC Filings: 10-K · 10-Q